This is a routine employee incentive grant with negligible dilution. No trading signal. Monitor upcoming quarterly results for revenue and pipeline progress.
ASND drugs
ASND drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 13 $275.39entry
- T+1 · 16h ago −1.33%α +0.58% · $271.73
- T+5 · in 3d Pending
- T+20 · in 27d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Ascendis Pharma filed its updated Articles of Association and disclosed a routine grant of 28,030 employee warrants at $256.59 per share. The filing is a governance update with no financial results or material business events.
Key Facts
- Board granted 28,030 warrants to employees on November 10, 2026 at $256.59 per share
- Warrants vest 25% after one year, then 1/36th monthly for remaining 75%
- After grant, 1,431,143 warrants remain available for future grant
- Articles of Association updated to reflect the grant and other historical warrant activity
- No financial results, guidance, or material corporate events reported
Financial Impact
28,030 warrants represent approximately 0.04% of outstanding shares (based on DKK 66.4M share capital at DKK 1 per share); minimal dilution
Risk Factors
- None from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001193125-26-458255 |
| Document: d179714d6k.htm | 0001193125-26-458255 |
| Document: 0001193125-26-458255-index-headers.html | 0001193125-26-458255 |
| Document: 0001193125-26-458255-index.html | 0001193125-26-458255 |
| Document: 0001193125-26-458255.txt | 0001193125-26-458255 |
| Earnings Context (Synthetic; results releases only) | 0001193125-26-458255 |
Track record
41 reports on ASND
14 of 19 bullish or bearish reports moved the stock their way by T+60. Best: +26.62% at T+20 after the Jun 2, 2026 report. 25 of 27 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $271.96 Now $271.73 −0.08% settles Feb 12
- Nov 12, 20264d ago 6-K Neutral 2/10 Viewing Entry $275.39 Now $271.73 −1.33% settles Feb 11
- Nov 12, 20264d ago 6-K Bullish 6/10 Entry $267.07 Now $271.73 +1.74% settles Feb 10
- Nov 12, 20264d ago Press Release Neutral 5/10 Entry $267.07 Now $271.73 +1.74% settles Feb 10
- Nov 6, 202610d ago 6-K Bullish 6/10 Entry $259.85 Now $271.73 +4.57% settles Feb 5
- Nov 6, 202610d ago Press Release Bullish 6/10 Entry $256.82 Now $271.73 +5.81% settles Feb 4
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $253.45 Now $271.73 +7.21% settles Feb 3
- Nov 2, 202614d ago Institutional Cluster Bullish 4/10 Entry $250.17 Now $271.73 +8.62% settles Feb 1
- Oct 26, 202621d ago 6-K Bullish 5/10 Entry $245.85 Now $271.73 +10.53% settles Jan 25
- Oct 16, 20264w ago 6-K Bullish 7/10 Entry $225.25 Now $271.73 +20.63% settles Jan 13
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers